Liou Fang-Yu, Tsai Min-Shan, Kuo Li-Kuo, Hsu Hsin-Hui, Lai Chih-Hung, Lin Kun-Chang, Huang Wei-Chun
Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Education Center, National Cheng Kung University, Tainan, Taiwan.
Front Med (Lausanne). 2022 Apr 13;9:779781. doi: 10.3389/fmed.2022.779781. eCollection 2022.
Targeted temperature management (TTM) is associated with decreased mortality and improved neurological function after cardiac arrest. Additionally, studies have shown that bystander cardiopulmonary resuscitation (BCPR) doubled the survival of patients with out-of-hospital cardiac arrest (OHCA) compared to patients who received no BPCR (no-BCPR). However, the outcome benefits of BCPR on patients who received TTM are not fully understood. Therefore, this study aimed to investigate the outcome differences between BCPR and no-BCPR in patients who received TTM after cardiac arrest.
The Taiwan Network of Targeted Temperature Management for Cardiac Arrest (TIMECARD) multicenter registry established a study cohort and a database for patients receiving TTM between January 2013 and September 2019. A total of 580 patients were enrolled and divided into 376 and 204 patients in the BCPR and no-BCPR groups, respectively.
Compared to the no-BCPR group, the BCPR group had a better hospital discharge and survival rate (42.25 vs. 31.86%, = 0.0305). The BCPR group also had a better neurological outcome at hospital discharge. It had a higher average GCS score (11.3 vs. 8.31, < 0.0001) and a lower average Glasgow-Pittsburgh cerebral performance category (CPC) scale score (2.14 vs. 2.98, < 0.0001). After undertaking a multiple logistic regression analysis, it was found that BCPR was a significant positive predictor for in-hospital survival (OR = 0.66, 95% CI: 0.45-0.97, = 0.0363).
This study demonstrated that BCPR had a positive survival and neurological impact on the return of spontaneous circulation (ROSC) in patients receiving TTM after cardiac arrest.
目标温度管理(TTM)与心脏骤停后死亡率降低及神经功能改善相关。此外,研究表明,与未接受旁观者心肺复苏(BCPR)的院外心脏骤停(OHCA)患者相比,接受BCPR的患者生存率提高了一倍。然而,BCPR对接受TTM的患者的预后益处尚未完全明确。因此,本研究旨在探讨心脏骤停后接受TTM的患者中BCPR与未接受BCPR的患者的预后差异。
台湾心脏骤停目标温度管理网络(TIMECARD)多中心注册研究建立了一个研究队列和一个数据库,纳入2013年1月至2019年9月期间接受TTM的患者。共纳入580例患者,分别分为BCPR组376例和未接受BCPR组204例。
与未接受BCPR组相比,BCPR组的出院率和生存率更高(42.25%对31.86%,P = 0.0305)。BCPR组出院时的神经功能结局也更好。其平均格拉斯哥昏迷量表(GCS)评分更高(11.3对8.31,P < 0.0001),平均格拉斯哥-匹兹堡脑功能分类(CPC)量表评分更低(2.14对2.98,P < 0.0001)。进行多因素逻辑回归分析后发现,BCPR是院内生存的显著正性预测因素(比值比[OR] = 0.66,95%置信区间[CI]:0.45 - 0.97,P = 0.0363)。
本研究表明,BCPR对心脏骤停后接受TTM的患者自主循环恢复(ROSC)的生存及神经功能有积极影响。